chronic abdominal pain adults
Posted by admin on 1 April, 2011
No comments yet
This item was filled under [ Most Popular ]
New Data Analyses with VICTRELIS™ (boceprevir), Merck’s Investigational Medicine, Examined Possible Predictors of …
Merck , known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS™ to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.
Childrens Health Experts – Our mission
